Leslie («Les») Brun

Founding Partner, Member of the Global Strategy Committee, Chairman of the Private Equity Investment Committee

Founder, Chairman, CEO and controlling shareholder of Hamilton Lane (Nasdaq: HLNE), the world’s leading Private Equity advisory and management firm. He sold his controlling participation to a consortium led by Cascade, the investment arm of Bill Gates in 2003
40+ years in investment banking, commercial banking and financial advisory experience with Chemical Bank, Fidelity Bank, E.F Hutton and Lloyds International Corporation
Chairman and CEO of Sarr Group, his holding company
Currently Chairman of the Board of Director of CDK Global, Inc. (NASDAQ “CDK”). He is Lead Director of Merck & Co., Inc. (NYSE “MRK”) and Broadridge Financial Solutions, Inc. (NYSE “BR”), where he was formerly Chairman of the Board of Directors. He also serves on the Board of Directors of Thoma Bravo Advantage, Inc. (NYSE: “TBA”), Corning, Inc. (NYSE “GLW”), Ariel Investments, LLC, and Footprint, LLC.

Formerly, Chair of ADP (the world’s largest data processor), Chair of Compensation Committee and Board Member of Hewlett Packard Enterprise, Chairman of the US Small Business Administration’s Advisory Council and Managing Director of CCMP Capital Advisors
BS from the State University of New York (recognized as a Distinguished Alumnus), and former Trustee of the University at Buffalo Foundation
Les was recognized as one of America’s top 100 Corporate Directors by the National Association of Corporate Directors
Les was inducted to the 2019 Business Hall of Fame for Philadelphia Inquirer’s Industry Icons